TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17552374

Group type: EXPERIMENTAL
Intervention: Gaboxadol 5 mg (GBX5)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Gaboxadol 10 mg (GBX10)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Gaboxadol 15 mg (GBX15)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg (ZOL10)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 109
Study: 15769761

Group type: EXPERIMENTAL
Intervention: Invasive treatment strategy
Number of subjects: 2183

Group type: EXPERIMENTAL
Intervention: Non-protocol-guided care
Number of subjects: 2183

Group type: COMPARATOR
Intervention: Invasive strategy
Number of subjects: 2183
Study: 11130129

Group type: EXPERIMENTAL
Intervention: TIVA with propofol (4 mg/kg/h) and remifentanil (0.25 microgram/kg/min)
Number of subjects: 22

Group type: COMPARATOR
Intervention: TIVA with propofol (4 mg/kg/h) and sufentanil (1 microgram/kg)
Number of subjects: 22
Study: 9175664

Group type: EXPERIMENTAL
Intervention: Closure of subcutaneous fat tissue
Number of subjects: 164

Group type: COMPARATOR
Intervention: No closure of subcutaneous fat tissue
Number of subjects: 164
Study: 1606772

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide for 6 months, warfarin and dipyridamole for two years
Number of subjects: 40

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 40
Study: 2581010

Group type: EXPERIMENTAL
Intervention: Parathyroidectomy (PTX)
Number of subjects: 10
Study: 31908212

Group type: EXPERIMENTAL
Intervention: SurgeMan®
Number of subjects: 45

Group type: COMPARATOR
Intervention: TraumaMan®
Number of subjects: 45

Group type: COMPARATOR
Intervention: Porcine models
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: All three models
Number of subjects: 45
Study: 29361834

Group type: COMPARATOR
Intervention: High-Intensity Resistance Training (HIGH)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Moderate-Intensity Resistance Training (MOD)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Exercise Groups (HIGH and MOD)
Number of subjects: 103
Study: 27349668

Group type: EXPERIMENTAL
Intervention: TTM-based exercise counseling combined with music skipping rope exercise for 12 weeks
Number of subjects: 75

Group type: COMPARATOR
Intervention: One session of exercise counseling with music skipping rope exercise for 12 weeks
Number of subjects: 75
Study: 23733767

Group type: EXPERIMENTAL
Intervention: Schedule A: decitabine 20 mg/m² SC per day for 3 consecutive days on days 1, 2, and 3 every 28 days
Number of subjects: 65

Group type: COMPARATOR
Intervention: Schedule B: decitabine 20 mg/m² SC per day once every 7 days on days 1, 8, and 15 every 28 days
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Schedule A
Number of subjects: 65

Group type: COMPARATOR
Intervention: Schedule B
Number of subjects: 65
Study: 20496049

Group type: EXPERIMENTAL
Intervention: 2:1 diet
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 10:1 + S diet
Number of subjects: 24

Group type: COMPARATOR
Intervention: 10:1 diet
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 2:1 + S diet
Number of subjects: 24
Study: 18925510

Group type: EXPERIMENTAL
Intervention: Transfusion volume of 10 ml/kg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Transfusion volume of 15 ml/kg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 20
Study: 16649866

Group type: EXPERIMENTAL
Intervention: Unresolved trauma
Number of subjects: 60
Study: 12790159

Group type: EXPERIMENTAL
Intervention: 0.3 mg of melatonin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1.0 mg of melatonin
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 10781447

Group type: EXPERIMENTAL
Intervention: EMLA cream (5 g per chest tube cutaneously 3 h before CTR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: IV morphine (0.1 mg/kg up to 10 mg IV 30 min before CTR)
Number of subjects: 120
Study: 8882074

Group type: EXPERIMENTAL
Intervention: Salmeterol 50 micrograms twice daily
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 1430301

Group type: EXPERIMENTAL
Intervention: Morning dose of 200 mg valproic acid (VPA) after a light meal
Number of subjects: 16

Group type: COMPARATOR
Intervention: Evening dose of 200 mg valproic acid (VPA) after a heavy meal
Number of subjects: 16

Group type: COMPARATOR
Intervention: Evening dose of 200 mg valproic acid (VPA) after a light meal
Number of subjects: 16
Study: 3005756

Group type: EXPERIMENTAL
Intervention: Short‐acting steroid (fluocortolone or prednisone) on three out of four days
Number of subjects: 31

Group type: COMPARATOR
Intervention: Daily steroid treatment (15 mg prednisone or more per day)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Normal subjects
Number of subjects: 31
Study: 30089116

Group type: EXPERIMENTAL
Intervention: Integrated mathematics/geometry and physical activity program (experimental group, n1 = 19)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Traditional teaching methods (control group, n2 = 17)
Number of subjects: 36
Study: 27339562

Group type: EXPERIMENTAL
Intervention: Problem-based learning
Number of subjects: 146

Group type: COMPARATOR
Intervention: Lecture-based learning
Number of subjects: 146
Study: 24656872

Group type: EXPERIMENTAL
Intervention: Consumption of fruits (80 g) and vegetables (60 g)
Number of subjects: 388

Group type: COMPARATOR
Intervention: Family income higher than four minimum wages
Number of subjects: 388

Group type: COMPARATOR
Intervention: Lower paternal educational level
Number of subjects: 388

Group type: COMPARATOR
Intervention: Lower fruit consumption at 12-16 months
Number of subjects: 388

Group type: COMPARATOR
Intervention: Consumption of high-sugar content beverages at 12-16 months
Number of subjects: 388
Study: 22069111

Group type: EXPERIMENTAL
Intervention: DWI group (echo‐planar DW stimulation)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: T1 group (T1‐weighted stimulation)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Sham group (no magnetic stimulation)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Comparison of MR stimulation (DWI or T1) vs. sham group
Number of subjects: 51
Study: 19962289

Group type: EXPERIMENTAL
Intervention: Hibiscus sabdariffa extract powder (HSEP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hibiscus sabdariffa extract powder (HSEP) plus diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Preventive treatment (diet)
Number of subjects: 0
Study: 18319697

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Diagnostic coronary angiography
Number of subjects: 20
Study: 18661258

Group type: EXPERIMENTAL
Intervention: Protein (15 g of whey both before and after exercise)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo (non-energetic placebo)
Number of subjects: 31
Study: 16311444

Group type: EXPERIMENTAL
Intervention: Electromyography (EMG) and mechanical myotonometry (MYO, frequency and decrement of decay)
Number of subjects: 0
Study: 11532533

Group type: EXPERIMENTAL
Intervention: Nortriptyline (25-100 mg/day)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Sertraline (50-150 mg/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Normal control group (n=19)
Number of subjects: 22
Study: 9172067

Group type: EXPERIMENTAL
Intervention: MeSH term searches
Number of subjects: 0

Group type: COMPARATOR
Intervention: Textword searches
Number of subjects: 0
Study: 7955872

Group type: EXPERIMENTAL
Intervention: Citramag (2 sachets)
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Picolax
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Picolax with cleansing enema
Number of subjects: 196

Group type: COMPARATOR
Intervention: Picolax and Citramag
Number of subjects: 196
Study: 3442758

Group type: EXPERIMENTAL
Intervention: Diazepam-Ketamine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Fentanyl-Methohexital
Number of subjects: 100
Study: 12568180

Group type: EXPERIMENTAL
Intervention: Erythromycin 250 mg i.v. every 8 hours
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 29439668

Group type: EXPERIMENTAL
Intervention: Adjuvant HIPEC with Mitomycin C (60 min at 42-43 °C) followed by routine adjuvant systemic chemotherapy
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard treatment (systemic chemotherapy only)
Number of subjects: 200
Study: 27173814

Group type: EXPERIMENTAL
Intervention: CRP pretest group
Number of subjects: 401

Group type: COMPARATOR
Intervention: Control group (no pretest)
Number of subjects: 401
Study: 25114132

Group type: EXPERIMENTAL
Intervention: 4 g PAS twice daily
Number of subjects: 73

Group type: COMPARATOR
Intervention: 8 g PAS once daily
Number of subjects: 73

Group type: COMPARATOR
Intervention: Concurrent efavirenz (EFV) medication
Number of subjects: 73
Study: 22369032

Group type: COMPARATOR
Intervention: ICSI using motile spermatozoon with normal morphology injected into metaphase‐II (M‐II) oocyte (Group A1)
Number of subjects: 96

Group type: COMPARATOR
Intervention: ICSI using spermatozoon showing coiling of tail (Group B1)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: ICSI using spermatozoan with birefringent head (Group A2)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: ICSI using spermatozoan with birefringent head (Group B2)
Number of subjects: 96
Study: 20470675

Group type: EXPERIMENTAL
Intervention: 532 nm laser therapy with retinaldehyde-based topical application
Number of subjects: 14

Group type: COMPARATOR
Intervention: 532 nm laser therapy alone
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control side (untreated)
Number of subjects: 14
Study: 18318871

Group type: EXPERIMENTAL
Intervention: Reducing the Risk curriculum
Number of subjects: 1944

Group type: EXPERIMENTAL
Intervention: Modified Reducing the Risk curriculum
Number of subjects: 1944

Group type: COMPARATOR
Intervention: Standard pregnancy and HIV prevention curriculum
Number of subjects: 1944
Study: 15897496

Group type: EXPERIMENTAL
Intervention: Chronic bilateral STN stimulation (STN-S)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Drug therapy alone (control)
Number of subjects: 39
Study: 12552351

Group type: EXPERIMENTAL
Intervention: Intravenous administration of [(123)I]IPT
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (normal children)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Drug-naive children with ADHD
Number of subjects: 15
Study: 10330212

Group type: EXPERIMENTAL
Intervention: Facial Action Coding System
Number of subjects: 28
Study: 7546496

Group type: EXPERIMENTAL
Intervention: Low sodium-based diet advised by a nutritionist
Number of subjects: 95

Group type: COMPARATOR
Intervention: Blood pressure control group
Number of subjects: 95

Group type: COMPARATOR
Intervention: Time control group
Number of subjects: 95
Study: 2028789

Group type: EXPERIMENTAL
Intervention: Positive Expiratory Pressure (PEP) mask as a method of chest physiotherapy
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: PEP mask in conjunction with Forced Expiratory Technique (FET)
Number of subjects: 28
Study: 7317246

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate 10 microgram kg‐1 i.v.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atropine 20 microgram kg‐1 i.v.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral atropine 30 microgram kg‐1 90 min before operation
Number of subjects: 0
Study: 30442329

Group type: EXPERIMENTAL
Intervention: Integrated cognitive behavioral therapy (ICART)
Number of subjects: 55

Group type: COMPARATOR
Intervention: MET-CBT
Number of subjects: 55
Study: 29120255

Group type: EXPERIMENTAL
Intervention: Dexamethasone + Bromfenac
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Dexamethasone + Nepafenac
Number of subjects: 144

Group type: COMPARATOR
Intervention: Dexamethasone alone (Control group)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: All groups (Dexamethasone + Bromfenac, Dexamethasone + Nepafenac, Dexamethasone alone)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Nepafenac group
Number of subjects: 144
Study: 27513344

Group type: EXPERIMENTAL
Intervention: Topical Pidobenzone 4% combined with fractional CO2 laser or cryotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physical therapy alone
Number of subjects: 0
Study: 24123094

Group type: EXPERIMENTAL
Intervention: Dose C (10 mg mane and 5 mg tarde)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Dose A (20 mg mane and 10 mg tarde)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Dose B (10 mg mane and 10 mg tarde)
Number of subjects: 10
Study: 21972847

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine (daily immersion for 20 minutes after dinner)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2.0% chlorhexidine (single immersion for 5 minutes at the end of the experimental period)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (daily overnight soaking in water)
Number of subjects: 60
Study: 20200041

Group type: EXPERIMENTAL
Intervention: Imatinib, 400 mg orally once daily for 1 year
Number of subjects: 713

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 713
Study: 18567762

Group type: EXPERIMENTAL
Intervention: Fortified cheddar cheese (DC)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Fortified low‐fat cheese (DLF)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Liquid vitamin D supplement with food (DS+)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Liquid vitamin D supplement without food (DS‐)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo cheddar cheese
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo supplement
Number of subjects: 80
Study: 16084849

Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg daily) with Indinavir (800 mg) and Ritonavir (100 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Diltiazem (120 mg daily) with Indinavir (800 mg) and Ritonavir (100 mg)
Number of subjects: 18
Study: 12514444

Group type: EXPERIMENTAL
Intervention: Not applicable (observational study)
Number of subjects: 144
Study: 11253442

Group type: EXPERIMENTAL
Intervention: Intensive nutritional intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nutrition session attendance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Changes in psychosocial factors
Number of subjects: 0
Study: 8958015

Group type: EXPERIMENTAL
Intervention: Turbo fast low angle shot MRI during drug‐induced sleep
Number of subjects: 15

Group type: COMPARATOR
Intervention: Visual inspection while awake
Number of subjects: 15
Study: 1415200

Group type: EXPERIMENTAL
Intervention: Enisoprost (EP) 100 micrograms orally four times daily for 2 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 40
Study: 3905211

Group type: EXPERIMENTAL
Intervention: High P/S ratio diet (1.0)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Low P/S ratio diet (0.3)
Number of subjects: 54
Study: 30963721

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) intervention for 6 months, mean of 6.5 sessions delivered face to face and via telephone.
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (usual care) for 6 months.
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) intervention.
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (usual care).
Number of subjects: 39
Study: 29420200

Group type: EXPERIMENTAL
Intervention: Anifrolumab 300 mg
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Anifrolumab 1,000 mg
Number of subjects: 305

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305
Study: 26746456

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Caloric restriction (diet)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Combination of exercise and diet
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (attention control)
Number of subjects: 100
Study: 24823465

Group type: EXPERIMENTAL
Intervention: Combined treatment (COM) with MET 1000 mg twice a day and roflumilast 500 μg every day
Number of subjects: 36

Group type: COMPARATOR
Intervention: Metformin (MET) 1000 mg twice a day
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Combined treatment (COM)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Metformin (MET)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both treatment interventions
Number of subjects: 36
Study: 22702724

Group type: EXPERIMENTAL
Intervention: Training (T)
Number of subjects: 641

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 641
Study: 20144231

Group type: EXPERIMENTAL
Intervention: HER2_2 score
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: PGR_5 score
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: PRO_10 score
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: RISK_25 score
Number of subjects: 342

Group type: EXPERIMENTAL
Intervention: PRO_10 and PGR_5 scores
Number of subjects: 342
Study: 18394099

Group type: EXPERIMENTAL
Intervention: Nasal respiratory support (nasal continuous positive airway pressure or nasal intermittent mandatory ventilation)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Spontaneous breathing without nasal respiratory support
Number of subjects: 54
Study: 16473215

Group type: COMPARATOR
Intervention: On-axis incisions (OAI)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Limbal relaxing incisions (LRI)
Number of subjects: 71
Study: 12722398

Group type: EXPERIMENTAL
Intervention: Carboplatin with paclitaxel for platinum-sensitive patients
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Paclitaxel, topotecan, or liposomal doxorubicin for platinum-resistant cases
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: New agents introduced into therapy
Number of subjects: 28
Study: 9502647

Group type: EXPERIMENTAL
Intervention: Complete AVJ ablation with permanent pacing
Number of subjects: 60

Group type: COMPARATOR
Intervention: AVJ modification
Number of subjects: 60
Study: 8116037

Group type: EXPERIMENTAL
Intervention: PTX 800 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2506913

Group type: EXPERIMENTAL
Intervention: Cromolyn sodium (Nalcrom) 200 mg orally, four times daily, starting 3 days before and continuing up to 3 days after food ingestion challenge.
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 1069551

Group type: EXPERIMENTAL
Intervention: Neuraminidase-treated allogeneic myeloblasts
Number of subjects: 17

Group type: COMPARATOR
Intervention: Sustaining chemotherapy alone
Number of subjects: 17
Study: 30021394

Group type: EXPERIMENTAL
Intervention: Nutraceutical compounds (NCs) containing red yeast rice and coenzyme Q10 added to diet for 2 months
Number of subjects: 104

Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 104
Study: 27095389

Group type: EXPERIMENTAL
Intervention: Conventional therapy plus ketamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 0
Study: 23871707

Group type: EXPERIMENTAL
Intervention: Portable, accelerometer-based navigation device
Number of subjects: 100

Group type: COMPARATOR
Intervention: Extramedullary (EM) alignment guides
Number of subjects: 100
Study: 23023384

Group type: EXPERIMENTAL
Intervention: Betamethasone treatment
Number of subjects: 80
Study: 20816299

Group type: EXPERIMENTAL
Intervention: Facial mask and bite-block appliance
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (12 untreated Class III subjects)
Number of subjects: 22
Study: 18417969

Group type: EXPERIMENTAL
Intervention: X3 (X2 plus interpersonal phone contact)
Number of subjects: 444

Group type: COMPARATOR
Intervention: X1 (standard direct‐mailed procedures)
Number of subjects: 444

Group type: COMPARATOR
Intervention: X2 (X1 plus culturally tailored materials)
Number of subjects: 444
Study: 16235674

Group type: EXPERIMENTAL
Intervention: Type 1 (prospective randomized controlled trials)
Number of subjects: 786

Group type: EXPERIMENTAL
Intervention: Type 2 (other prospective studies)
Number of subjects: 786

Group type: EXPERIMENTAL
Intervention: Type 3 (retrospective case‐controlled studies)
Number of subjects: 786

Group type: COMPARATOR
Intervention: Type 4 (case reports)
Number of subjects: 786

Group type: EXPERIMENTAL
Intervention: Median number of patients
Number of subjects: 786

Group type: EXPERIMENTAL
Intervention: Mean number of authors per study
Number of subjects: 786

Group type: COMPARATOR
Intervention: Mean number of authors per study in JNS
Number of subjects: 786
Study: 11806652

Group type: EXPERIMENTAL
Intervention: MTA
Number of subjects: 0

Group type: COMPARATOR
Intervention: IRM
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amalgam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Super‐EBA
Number of subjects: 0
Study: 10098764

Group type: EXPERIMENTAL
Intervention: Primary-care-centred follow-up
Number of subjects: 0

Group type: COMPARATOR
Intervention: Specialist-centred follow-up
Number of subjects: 0
Study: 7541089

Group type: EXPERIMENTAL
Intervention: Indeloxazine hydrochloride (INDX) with allylestrenol (ALE)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Allylestrenol (ALE) only
Number of subjects: 36
Study: 1978469

Group type: EXPERIMENTAL
Intervention: Chlorpromazine
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Remoxipride
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Both drugs (Chlorpromazine and Remoxipride)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 351804

Group type: EXPERIMENTAL
Intervention: Naloxone (specific dosage and duration not mentioned)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 7109747

Group type: EXPERIMENTAL
Intervention: Health-Belief-Model postcard
Number of subjects: 283

Group type: COMPARATOR
Intervention: Neutral postcard
Number of subjects: 283

Group type: COMPARATOR
Intervention: No postcard
Number of subjects: 283

Group type: COMPARATOR
Intervention: Personal postcard signed by physician
Number of subjects: 283
Study: 31008736

Group type: EXPERIMENTAL
Intervention: Pentazocine 30 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Diclofenac 75 mg
Number of subjects: 50
Study: 30203755

Group type: EXPERIMENTAL
Intervention: Ultrasonic atomized inhalation of antibiotics with targeted nursing
Number of subjects: 200
Study: 26655434

Group type: EXPERIMENTAL
Intervention: Home-based exercise program emphasizing aerobic and resistance training for 4 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 0
Study: 25138990

Group type: EXPERIMENTAL
Intervention: PlasmaKinetic urethrotomy
Number of subjects: 136

Group type: COMPARATOR
Intervention: Cold knife urethrotomy
Number of subjects: 136